Thus, an upregulation of CD8+ T cell cytolytic activity would be considered disadvantageous for cancer progression, which in turn results in a negative effect of interfering in platelet release for cytotoxic t-Lymphocyte-mediated tumour cell clearance. The gene discussed is CD8A; the disease is cancer.